Geode Capital Management
LIPO

Geode Capital Management’s Lipella Pharmaceuticals LIPO Stock Holding History

Geode Capital Management’s Portfolio LIPO Stock Details LIPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,114
Closed -$11.8K – 4492
2024
Q3 		$11.8K Sell
3,114
-136
-4% -$523 ﹤0.01% 4455
2024
Q2 		$12.1K Sell
3,250
-2,011
-38% -$11K ﹤0.01% 4523
2024
Q1 		$28.8K Hold
5,261
– – ﹤0.01% 4425
2023
Q4 		$42.9K Buy
+5,261
New +$49K ﹤0.01% 4385

Other funds holding LIPO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management's LIPO Position: Q4 2024 in Review

Geode Capital Management sold out of Lipella Pharmaceuticals (LIPO) in Q4 2024, closing a stake of 3,114 shares — an estimated $11.8K sold.

Geode Capital Management first reported a position in LIPO in Q4 2023 and held it in 4 quarters. The position peaked at $42.9K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIPO as of Q4 2024.

  • Geode Capital Management reported no remaining Lipella Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 3,114 Lipella Pharmaceuticals shares in Q4 2024, an estimated $11.8K.
  • Geode Capital Management first reported a position in Lipella Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Geode Capital Management's Lipella Pharmaceuticals position peaked at $42.9K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.